揭示1型布鲁加达模式后的Pilsicainide给药对帕洛克缩性心房动:一个案例报告
Yasushi Matsushita1,2, Naoyuki Otani3,4, Takashi Tomoe5
1Midorijuji Cinic Department of Cardiovascular Medicine, Yokohama, Japan.
JMA journal
|November 12, 2025
概括
布鲁加达综合征是一种遗传性心律失常,可以通过1型心电图样本来诊断. 该病例显示,在接受pilsicainide治疗的无症状患者中,药物诱导的1型布鲁加达心电图图案,突出显示需要保持警.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 布鲁加达综合征是一种遗传性心律失常,与心脏突然死亡有关.
- 一种1型布鲁加达心电图 (ECG) 模式是诊断性的,但可能很难检测到.
- 通道阻断剂可以诱导布鲁加达型心电图模式.
研究的目的:
- 报告一种药物诱导的1型布鲁加达心电图案例.
- 强调在服用通道阻断剂治疗的患者中识别药物诱导的心电图变化的重要性.
主要方法:
- 一个79岁的男性的病例报告,他因心房动而接受治疗.
- 使用pilsicainide,一种Cc类抗心律失常药物.
- 在治疗前后进行心电图 (ECG) 监测.
主要成果:
- 患者在服用pilsicainide后出现了1型布鲁加达心电图图案.
- 药物停用后3天内,心电图模式恢复正常.
- 在6个月的随访期间,没有观察到心室心律不整.
结论:
- 药物诱导的布鲁加达类型心电图图案是重要的,尤其是在无症状患者中.
- 无症状患者的预后与药物诱导的1型心电图一般是有利的.
- 临床医生在为心房动处方道阻塞剂时必须监测心电图变化.
相关概念视频
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
445
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
445
Dysrhythmias IV: Characteristics of Bradyarrhythmias
484
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
484
Dysrhythmias VI: Management of Dysrhythmias
422
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
422
Disturbances in Heart Rhythm
2.5K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
2.5K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.8K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.8K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
1.4K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
1.4K


